Olema Pharmaceuticals, Inc. (OLMA) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts OLMA Hot Sheet
Join SI Premium – FREE
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q4 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
- Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
